Trial updateCataract & IOL
Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)
Completed. Registered enrolment: 47. Edinburgh Biosciences Ltd
Why it matters
Track this study through NCT07246915. No results are posted in this registry record.
The study at a glance
- Registry status
- Completed
- Phase
- —
- Registered enrolment
- 47
- Results posted
- No
- Sponsor
- Edinburgh Biosciences Ltd
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.